Does Chantix (Varenicline) Work for Quitting Smoking?

How does varenicline work?

Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor — the receptor central to nicotine's addictive effect. In practical terms, this means:

1. It activates the receptor enough to reduce cravings and ease withdrawal. 2. It occupies the receptor, so if you do smoke, the cigarette produces less reward — making it less reinforcing.

This dual action distinguishes varenicline from nicotine replacement therapy (which replaces nicotine) and bupropion (which works on dopamine and norepinephrine without directly targeting nicotine receptors).

What does the evidence show about how well it works?

A 2023 Cochrane systematic review of randomized controlled trials found that varenicline substantially increases the likelihood of quitting compared to both placebo and to nicotine replacement therapy used alone 1Ref 1Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023).Nicotine Receptor Partial Agonists for Smoking Cessation.Varenicline outperforms NRT and placebo in head-to-head evidence; standard 12-week course; cardiovascular safety reassurance from more recent evidence. The EAGLES trial — a large, carefully designed comparison of varenicline, bupropion, nicotine patch, and placebo — confirmed varenicline's effectiveness across smokers both with and without psychiatric histories 2Ref 2Anthenelli RM, Benowitz NL, West R, et al. (2016).Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers with and without Psychiatric Disorders (EAGLES): A Double-Blind, Randomised, Placebo-Controlled Clinical Trial.Varenicline effectiveness confirmed across smokers with and without psychiatric histories; risk-benefit favors use even in psychiatric populations.

That said, effectiveness varies. The best outcomes in any individual come from combining medication with behavioral counseling or a structured quit program 3Ref 3US Preventive Services Task Force (2021).Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.Combination of medication and behavioral support produces better outcomes than medication alone. Medication alone leaves some people needing more support.

How do you take it?

Varenicline is typically started one to two weeks before your planned quit date, at a low dose that is increased over the first week. This gradual start reduces the nausea that is the most common side effect. The usual course is 12 weeks; extending to a second 12-week course is sometimes recommended to lower relapse risk 1Ref 1Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023).Nicotine Receptor Partial Agonists for Smoking Cessation.Varenicline outperforms NRT and placebo in head-to-head evidence; standard 12-week course; cardiovascular safety reassurance from more recent evidence. Your clinician will set the schedule.

Nausea and vivid dreams are the most commonly reported side effects. Both tend to improve after the first one to two weeks and are manageable for most people who use the medication as directed.

How does varenicline compare to other cessation options?

Head-to-head evidence generally places varenicline at or near the top of cessation medication effectiveness, with NRT and bupropion as the main alternatives 1Ref 1Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023).Nicotine Receptor Partial Agonists for Smoking Cessation.Varenicline outperforms NRT and placebo in head-to-head evidence; standard 12-week course; cardiovascular safety reassurance from more recent evidence.

• For someone with a history of seizures or eating disorders, bupropion is typically avoided — NRT or varenicline may be preferred.
• For someone who cannot tolerate varenicline's side effects, NRT or bupropion remain meaningful options.
• Combining varenicline with a nicotine patch is an area some clinicians explore — this requires an explicit discussion with your prescriber.
• Adding behavioral support (counseling, a quit line) improves outcomes on top of any medication 3Ref 3US Preventive Services Task Force (2021).Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.Combination of medication and behavioral support produces better outcomes than medication alone.

Who should discuss varenicline carefully with a clinician?

Varenicline can be used by most adults who smoke, but certain situations deserve a careful prescribing conversation:

Mental health history: People with depression, bipolar disorder, or schizophrenia can still use varenicline, but closer mood monitoring is appropriate. The EAGLES trial found the risk-benefit ratio still favored use in people with psychiatric histories, though with a somewhat higher rate of neuropsychiatric events 2Ref 2Anthenelli RM, Benowitz NL, West R, et al. (2016).Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers with and without Psychiatric Disorders (EAGLES): A Double-Blind, Randomised, Placebo-Controlled Clinical Trial.Varenicline effectiveness confirmed across smokers with and without psychiatric histories; risk-benefit favors use even in psychiatric populations.

Heart disease: The benefit of quitting smoking for cardiovascular health is large. More recent evidence has been reassuring about varenicline's cardiovascular safety, but anyone with significant heart disease should review this with their clinician 1Ref 1Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. (2023).Nicotine Receptor Partial Agonists for Smoking Cessation.Varenicline outperforms NRT and placebo in head-to-head evidence; standard 12-week course; cardiovascular safety reassurance from more recent evidence.

Pregnancy: Safety data in pregnancy is limited; a clinician will weigh the options individually — quitting is the priority, and the right method needs individualized guidance 4Ref 4American College of Obstetricians and Gynecologists (2020).Tobacco and Nicotine Cessation During Pregnancy: ACOG Committee Opinion, Number 807.Limited safety data for varenicline in pregnancy; individualized clinician guidance required.

Kidney disease: Dose adjustment is sometimes needed; your clinician will assess this.